Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting

Nanotherapeutics relieve rheumatoid arthritis

(2017) Modi Yang et al.   JOURNAL OF CONTROLLED RELEASE

Folate-targeted nanoparticles for rheumatoid arthritis therapy

(2016) Eugénia Nogueira et al.   Nanomedicine-Nanotechnology Biology and Medicine

The pathogenic role of angiogenesis in rheumatoid arthritis

(2015) Hatem A. Elshabrawy et al.   ANGIOGENESIS

Drug-loaded gold/iron/gold plasmonic nanoparticles for magnetic targeted chemo-photothermal treatment of rheumatoid arthritis

(2015) Hyung Joon Kim et al.   BIOMATERIALS

Enhancing Methotrexate Tolerance with Folate Tagged Liposomes in Arthritic Mice

(2015) Eugénia Nogueira et al.   Journal of Biomedical Nanotechnology

Hyaluronate–Gold Nanoparticle/Tocilizumab Complex for the Treatment of Rheumatoid Arthritis

(2014) Hwiwon Lee et al.   ACS Nano

Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis

(2013) Seol-Hee Kim et al.   CHEMICAL COMMUNICATIONS

Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib

(2013) Upasana Bilthariya et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Anti-VCAM-1 and Anti-E-selectin SAINT-O-Somes for Selective Delivery of siRNA into Inflammation-Activated Primary Endothelial Cells

(2013) Piotr S. Kowalski et al.   MOLECULAR PHARMACEUTICS

Targeted Chemo-Photothermal Treatments of Rheumatoid Arthritis Using Gold Half-Shell Multifunctional Nanoparticles

(2012) Sun-Mi Lee et al.   ACS Nano

Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis

(2011) Thommey P. Thomas et al.   ARTHRITIS AND RHEUMATISM

Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting

(2010) Shyh-Dar Li et al.   JOURNAL OF CONTROLLED RELEASE

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

(2010) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis

(2010) Otilia May Yue Koo et al.   PHARMACEUTICAL RESEARCH